Author

Jackie Julien

Observed institutions: Memorial Sloan Kettering Cancer Center, University of California, Los Angeles

OpenAlex ID: A5032042452

Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts

2015 · Andiliy Lai, Mehmet Kahraman, et al. · Journal of Medicinal Chemistry · 261

Abstract C16: Targeting AR in castration-resistant prostate cancer: Development of ARN-509 and second-generation antiandrogen resistance models

2012 · James D. Joseph, Anna Aparicio, et al. · Cancer Research

Works count: 2

Citation count: 261

H-index: 1

I10-index: 1